
Loading, please wait...

Loading, please wait...

Hydrocephalus management in infants has evolved significantly with the introduction of endoscopic third ventriculostomy with choroid plexus cauterization (ETV/CPC). This procedure aims to reduce shunt dependence, yet accurately forecasting outcomes remains a clinical challenge. Traditionally, the ETV Success Score (ETVSS) has been the gold standard. However, recent research suggests that ETV/CPC success prediction can be vastly improved by using machine learning algorithms that incorporate previously overlooked anatomical variables.
While the ETVSS relies on age and etiology, it often fails to account for the specific impact of choroid plexus cauterization. Researchers recently analyzed data from 206 pediatric patients to develop a more robust predictive tool. They found that hydrocephalus etiology, a cornerstone of the ETVSS, was actually irrelevant to the performance of their models. Instead, the team utilized logistic regression and gradient boosting to identify more reliable predictors. Consequently, the new model offers a more personalized outlook for infants undergoing this definitive treatment.
A major breakthrough in this study was the inclusion of the frontal occipital horn ratio (FOHR). This measurement of preoperative ventricle size proved to be a critical determinant of long-term outcomes. By focusing on ETV/CPC success prediction through features like corrected age, prior CSF diversion, and FOHR, the logistic regression model achieved an AUROC of 0.85. This significantly outperformed the ETVSS, which scored only 0.66 in the same cohort. Furthermore, the model accounted for the complex interdependence between variables, which traditional scoring systems often ignore.
The ability to predict success at the one-year mark provides surgeons and families with much-needed clarity. Because the model achieves a 76% accuracy rate, it serves as a powerful decision-support tool. It successfully identifies candidates who are most likely to benefit from ETV/CPC, potentially reducing unnecessary shunt placements. Although further validation is required across diverse populations, this machine-learning approach represents a major leap forward in precision medicine for pediatric hydrocephalus.
The new machine learning model includes preoperative ventricle size (FOHR) and accounts for the effects of choroid plexus cauterization, whereas the ETVSS focuses primarily on age and etiology.
The researchers found that etiology did not substantially influence the machine learning model's predictions for ETV/CPC outcomes, making it less relevant than anatomical features like FOHR.
The logistic regression model demonstrated a classification accuracy of 76% and an AUROC of 0.85, indicating high reliability in predicting surgical success at one year.
Disclaimer: This content is for informational and educational purposes only and does not constitute medical advice. It is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Refer to the latest local and national guidelines for clinical practice.
References
Hartman E et al. Predicting endoscopic third ventriculostomy with choroid plexus cauterization success with machine learning: the importance of ventricle size and the irrelevance of etiology. J Neurosurg Pediatr. 2026 May 08. doi: 10.3171/2026.1.PEDS25684. PMID: 42102402.
Kulkarni AV, et al. The ETV Success Score: a contemporary resource for predicting the outcome of endoscopic third ventriculostomy in children with hydrocephalus. J Neurosurg Pediatr. 2009.
Warf BC. Comparison of endoscopic third ventriculostomy alone and combined with choroid plexus cauterization in infant hydrocephalus: a prospective study in Uganda. J Neurosurg. 2005.
"
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


A new machine learning model predicts ETV/CPC success in infants more accurately than ETVSS, highlighting the importance of preoperative ventricle size....
5 months ago

Explore vital recurrent stroke predictors in lacunar stroke patients managed with intensive blood pressure lowering. This analysis examines trial findings from SPS3 to uncover residual vascular risks, metabolic factors, and targeted secondary prevention strategies for high-risk neurological patients.
Today

Odisha has established India's first state-level clinical protocol specifically tailored for pregnant women with sickle cell disease. Developed with NHM and UNICEF, the framework provides structured antenatal screening, crisis mitigation, standardized referral pathways, and specialized interdisciplinary care.
Today

The Directorate General of Health Services directs Indian states to halt the hazardous reuse and reprocessing of single-use medical devices. Discover regulatory implications under the Drugs and Cosmetics Act, critical infection risks, legal liabilities, and operational changes required across clinical specialties.
Today

Mitochondria-targeted nanoparticles self-assembled from EGCG and L-glutamic acid effectively restore mitochondrial homeostasis, suppress synovial inflammation, and attenuate chondrocyte senescence in osteoarthritis, offering a promising disease-modifying nanotherapy.
Today

India is advancing preventive healthcare by integrating genomics, artificial intelligence, and quantum technologies. With the SANGAM programme sequencing one million Indian genomes, clinicians can unlock personalized therapies, detect cardiometabolic risks early, and curb the burden of diabetes and heart disease.
Today